BioCentury
ARTICLE | Company News

LGC, Tm Bioscience deal

April 7, 2003 7:00 AM UTC

TMC received a non-exclusive license to LGC's patents covering the CYP2D6 drug metabolism gene. TMC will use the gene as part of its Tag-It Mutation Detection Kit for P450-2D6. The kit identifies gen...